Article · Volume 13, Issue 51 · pp. 407–412
Omega‑3 Fish Oil Reduces Mortality Due to Severe Sepsis with Acute Gastrointestinal Injury Grade III
Huaisheng Chen1, Wei Wang2, Chengying Hong1, Ming Zhang3, Yingcai Hong4, Su Wang5, Huadong Zhang1
- 1Department of Intensive Care Unit, Shenzhen People’s Hospital, The Second Clinical Hospital of Jinan University, Dong Men North Road, Luohu District, Shenzhen, China.
- 2Department of Endocrinology, Shenzhen People’s Hospital, The Second Clinical Hospital of Jinan University, Dong Men North Road, Luohu District, Shenzhen, Guangdong, China.
- 3Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- 4The Chest Department of Shenzhen People’s Hospital, The Second Clinical Hospital of Jinan University, Shenzhen, Guangdong, China.
- 5The Cardiovascular and thoracic surgery ICU, PLA 305 Hospital, Beijing, China.
Abstract
Background: Sepsis plays an important role in acute gastrointestinal injury (AGI). Our research was designed to determine the effects of omega-3 fish oil (FO) in patients suffering from severe sepsis combined with AGI III, and the ability of FO to modulate immune function.Methods: Seventy- eight patients diagnosed with severe sepsis with AGI III and a need for mechanical ventilation were randomized to two groups. In the FO group, 50 g of long chain fatty acid soybean oil (n = 6) and 10 g of FO (n = 3) were administered as total parenteral nutrition (TPN). The control group was treated with 50 g of long chain fatty acid soybean oil without addition of FO to TPN.Results: At baseline, there were no significant differences between the two groups. The 60-day mortality was lower in the FO group. Multiple factor logistic regression analysis revealed that intra-abdominal pressure (IAP) and abdominal infection were correlated with the FO intervention. The patients with abdominal infection demonstrated a lower mortality rate, fewer CD3 T lymphocytes, and fewer helper/inducer T lymphocytes in the FO group compared with the control group. After 7 days, the Marshall Score was lower in the FO group than in the control group.Conclusion: FO has positive effects in terms of improving the long- term prognosis of patients with severe sepsis with AGI III. Patients with a high IAP and abdominal infection might experience greater benefit from FO. This effect might be due, in part, to immunomodulation.
Keywords: Acute gastrointestinal injury; multiple organ dysfunction syndrome; omega‑3 fish oil; severe sepsis
The full text of this article is available as a PDF. Open the PDF.
